Development and validation of a nomogram to evaluate the therapeutic effects of second-line axitinib in patients with metastatic renal cell carcinoma

The unpredictable biological behavior and tumor heterogeneity of metastatic renal cell carcinoma (mRCC) cause significant differences in axitinib efficacy. The aim of this study is to establish a predictive model based on clinicopathological features to screen patients with mRCC who can benefit from...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dengqiang, Lai, Peng, Zhang, Wen, Lin, Jinglai, Wang, Hang, Hu, Xiaoyi, Guo, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975492/
https://www.ncbi.nlm.nih.gov/pubmed/36874101
http://dx.doi.org/10.3389/fonc.2023.1071816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975492/
https://www.ncbi.nlm.nih.gov/pubmed/36874101
http://dx.doi.org/10.3389/fonc.2023.1071816

Ejemplares similares